NCT06225596 2026-04-15
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
BicycleTx Limited
Phase 2/3 Active not recruiting
BicycleTx Limited
National Cancer Institute (NCI)
Hoffmann-La Roche
Regeneron Pharmaceuticals
Universitätsklinikum Hamburg-Eppendorf
Semmelweis University
Shengjing Hospital
The Netherlands Cancer Institute